The transition from low to high GFAP expression in AD is primarily associated with GPC5, Lucp2, Lsamp, Trpm3, Nnat, NRXN1, Dlgap1, Ncam2, and Slc7a10 [15]. Here, NRXN1 is linked to Alzheimer disease.